Comparing SF-6D and EQ-5D utilities across groups differing in health status.
about
Patients with unexplained physical symptoms have poorer quality of life and higher costs than other patient groups: a cross-sectional study on burdenHealth-related quality of life and socioeconomic status: inequalities among adults with a chronic diseaseUsing qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's disease.Utility scores for different health states related to depression: individual participant data analysis.Using QALYs in telehealth evaluations: a systematic review of methodology and transparency.Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes StComparison between EQ-5D and SF-6D utility in rural residents of Jiangsu Province, ChinaHealth-related quality of life for pre-diabetic states and type 2 diabetes mellitus: a cross-sectional study in Västerbotten SwedenA comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD)Cost-utility analysis of posterior minimally invasive fusion compared with conventional open fusion for lumbar spondylolisthesis.Chronic rhinosinusitis: an under-researched epidemicThe Relationship between Diabetes Mellitus and Health-Related Quality of Life in Korean Adults: The Fourth Korea National Health and Nutrition Examination Survey (2007-2009).Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling.The Relationship between Visual Impairment and Health-Related Quality of Life in Korean Adults: The Korea National Health and Nutrition Examination Survey (2008-2012).Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trialJapanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom.Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults.Agreement about identifying patients who change over time: cautionary results in cataract and heart failure patients.The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus.Systematic review and empirical comparison of contemporaneous EQ-5D and SF-6D group mean scores.Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes.Suitability of the Epworth Sleepiness Scale (ESS) for Economic Evaluation: An Assessment of Its Convergent and Discriminant Validity.Mapping Between the Sydney Asthma Quality of Life Questionnaire (AQLQ-S) and Five Multi-Attribute Utility Instruments (MAUIs).International Prostate Symptom Score Should Be Considered a Complement Rather Than a Substitute to Generic Preference-Based Measures for Measuring Lower Urinary Tract Symptoms Within Economic Evaluation.Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes.Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.Utility Scores In Patients With Oxygen-Dependent COPD: A Case-Control Study.Population norms for the EQ-5D index scores using Singapore preference weights.The potential for a generally applicable mapping model between QLQ-C30 and SF-6D in patients with different cancers: a comparison of regression-based methods.Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention?Exploration of health dimensions to be included in multi-attribute health-utility assessment.Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications.Is there a difference between EQ-5D and SF-6D in the clinical setting? a comparative study on the quality of life measured by AIMS2-SF, EQ-5D and SF-6D scales for osteoarthritis patients.
P2860
Q31146130-437E8B97-3F0A-4843-85C4-FC253075D467Q33573045-2BA4E0F4-2747-4E71-9010-B78F48BBAF93Q33748839-362E604D-7C4F-432D-836E-D7F0DCE98869Q33841729-B0524530-EC57-4831-A314-7191838F7828Q34042483-81A81325-4FFB-4879-94F1-6E4771784093Q34275175-760EE072-7B56-4BED-A09B-9C4D10A84DA3Q34358609-C8B11DC4-3B89-473C-B1E2-BFEF774233C3Q34416929-9FCD127B-5613-4951-BE49-36E209EBFC60Q34473088-F13A354A-AF58-41E7-B089-16A617959003Q35194280-BD089F41-F700-4CAA-B55B-F338D03B7E7DQ35226181-21DC9C11-072C-4EEE-9365-31E1463C3365Q35661431-EC1B72CB-7310-4750-983E-C433F8800105Q35666642-D170D82D-C9EC-418F-BA9D-39BC255602CBQ35699060-AEEB80F3-0EEC-42B7-AD58-7264FD107FF1Q36431528-1F1BC3E0-5D3E-4A58-803C-EFAE3FB7EE8CQ36594761-F8AAD7EA-C950-4D9D-8954-65899342C74DQ36888434-12C5962A-34F6-4A92-B9E0-B27E41159158Q36980775-33A1C696-3809-43EC-B91A-FF273C351D32Q37112087-1953457B-ED1E-4F2E-8C10-FE06B681F69EQ37851559-2147BFB2-C45D-4124-9091-B7FECE433226Q37945042-20EDFF9F-6FEC-4FE3-85F3-9B5F94583917Q38863771-A0511571-AC4B-4E8A-AADB-609D7BBD3576Q39277400-FB29E4E1-F06F-42E9-96D1-896EFF643603Q39456662-2FE05951-05C6-4B15-AAC7-20BB272C7050Q39561743-AAB0063C-9680-472A-AA19-6F55EAB8942AQ43142540-63C32FD7-8DE9-430B-AF7E-6CC71CE45B71Q45330205-8ADA9551-F7E7-4BAC-96A6-07815A39A7D7Q46631644-F1DDE5CA-7519-46F5-8CBD-77BBB621C3AFQ48045711-FD629D9D-37DA-4A0E-83BF-5CB143DD7BEAQ48059934-F871A554-3041-4B5B-B0D5-940C5250ED94Q48060040-5C4BDC33-7188-4981-A544-FCD090D335EDQ48315614-1053B5BE-49E3-4817-9356-E1B586787CCAQ48331289-745E234A-E190-48B3-9373-F1C1B9410915Q48737171-2B69EF60-A7AF-4ACF-94ED-DD05A4DAC689Q53812039-7C63B34B-ACD9-4DCA-BC75-F91D42C99FE8
P2860
Comparing SF-6D and EQ-5D utilities across groups differing in health status.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Comparing SF-6D and EQ-5D utilities across groups differing in health status.
@en
Comparing SF-6D and EQ-5D utilities across groups differing in health status.
@nl
type
label
Comparing SF-6D and EQ-5D utilities across groups differing in health status.
@en
Comparing SF-6D and EQ-5D utilities across groups differing in health status.
@nl
prefLabel
Comparing SF-6D and EQ-5D utilities across groups differing in health status.
@en
Comparing SF-6D and EQ-5D utilities across groups differing in health status.
@nl
P2093
P2860
P1476
Comparing SF-6D and EQ-5D utilities across groups differing in health status.
@en
P2093
Angelos A Papadopoulos
Evelina Pappa
Nick Kontodimopoulos
Yannis Tountas
P2860
P2888
P356
10.1007/S11136-008-9420-8
P577
2008-11-29T00:00:00Z
P6179
1016191941